CSHL Story archive for Tag: cancer research

Adrian Krainer wins Zülch Prize for lifesaving SMA Treatment

October 8, 2019

Professor Adrian Krainer is awarded the K-J. Zülch Prize for the development and testing of a first-of-its-kind treatment for spinal muscular atrophy.

Discovery could improve MDS cancer treatment

September 25, 2019

Researchers have discovered a promising new target for treating myelodysplastic syndrome (MDS), a common and lethal blood cancer.

Cancer drugs don’t always work as intended, researchers warn

September 11, 2019

Ten experimental cancer drugs kill tumors in ways that are entirely different than how clinicians thought they did, revealing important insights.

Overcoming resistance in pancreatic cancer

September 9, 2019

Controlling pancreatic tumor proliferation by targeting malignancy-specific resistance pathways in response to AKT and MAPK blockade.

How a lab and its model animals changed science

August 13, 2019

The natural history of science at Cold Spring Harbor Laboratory through the lens of animal research.

Understanding pregnancy’s effects on breast cancer risk

August 13, 2019

CSHL researchers authored a review in the journal Cell covering the landscape of breast cancer research.

An Angel’s Wish Gala Dinner-Dance

August 8, 2019

Of mice and model organisms

July 31, 2019

An in-depth look at how veterinarians at CSHL help take care of the various organisms that help researchers answer fundamental biological questions.

Sheltzer wins Presidential Early Career Award

July 9, 2019

CSHL Fellow Jason Sheltzer is a recipient of the Presidential Early Career Award for Scientists and Engineers for his work in cancer research.

Cancer cell’s “self eating” tactic may be its weakness

July 1, 2019

Pancreatic cancer cells are eating their own mitochondria to survive and spread. New research reveals how, hinting at a possible new drug target.

Sugars that coat proteins are a possible drug target for pancreatitis

June 20, 2019

CA19-9, a complex sugar structure coating proteins, represents a possible drug target for treatment of pancreatitis and prevention of pancreatic cancer.

Special fibroblasts help pancreatic cancer cells evade immune detection

June 13, 2019

Researchers found a specific type of cancer-associated fibroblast interacts with the immune system to help pancreatic cancer cells stay under the radar.

Fighting cancer in 3D

June 7, 2019

David Tuveson, Director of the CSHL Cancer Center, shares insights about his work on organoid technology.

Enzyme PHLPP2 could be a viable drug target for treating prostate cancer

May 15, 2019

Researchers have identified an enzyme called Phlpp2 as an attractive drug target for treating prostate cancer.

CSHL President elected as AACR Academy Fellow

March 25, 2019

CSHL President and CEO Dr. Bruce Stillman has been elected to the AACR Academy as part of the 2019 Fellows class.